Impact of treatment with benznidazole on conventional serology in chronic Chagas disease.

(a) The latest available serological data at the end of the study was considered for analysis.(b) The figures represent the number of subjects with the indicated changes out of the total evaluated (%).(c) Includes subjects with decrease of titers or seronegative conversion on 2 or 3 tests.